Emre S, Bilge I, Sirin A, Kilicaslan I, Nayir A, Oktem F, Uysal V
Department of Pediatric Nephrology, University of Istanbul, Medical Faculty, Istanbul, Turkey.
Nephron. 2001 Feb;87(2):118-26. doi: 10.1159/000045899.
We aimed to review our experience with childhood lupus nephritis (LN) in respect to the analysis of the clinical and histopathological presentation of LN and prognostic factors affecting the kidney and patient outcomes.
Forty-three children (39 girls, 4 boys) with biopsy-proven LN were included in the study. The mean age of the children was 12.0 +/- 2.8 years. Based on the renal histopathology and clinical presentation, patients were treated with oral prednisone, intravenous pulses of methylprednisolone or intravenous cyclophosphamide. The final clinical status was classified as follows: (1) renal and extrarenal remission; (2) clinically active renal disease, or (3) adverse outcome, i.e., end-stage renal failure (ESRF) or death.
The mean duration of follow-up was 7.2 +/- 2.8 years (1 month to 14.2 years). All 43 children had hematuria and 53.5% had proteinuria at admission. Fourteen children were in nephrotic status at the onset of disease. Class IV (diffuse proliferative) nephritis was observed in 29 patients as the most frequent histopathology (67.4%). The patients with class IV nephritis had a tendency to develop nephrotic syndrome, heavy proteinuria, increased Cr levels and persistent hypertension at initial evaluation. Thirty-two of 43 children (74.4%) were in renal remission at the last visit. Five-year kidney and patient survival rates from the time of diagnosis to the endpoints of ESRF or death were 83.7 and 90.7% respectively in the whole group while it was 75.9 and 86.2% respectively in the class IV group. Adverse outcome was significantly associated with the persistent hypertension, anemia, high serum Cr level, heavy proteinuria, nephrotic syndrome and class IV nephritis at presentation.
We can conclude that the prognosis of LN in children is primarily dependent on the histopathological lesions. Severity of the clinical renal disease at admission and presence of persistent hypertension are the main poor prognostic factors rather than age, gender, low C3 and C4 levels, ANA positivity and the treatment modalities in Turkish children.
我们旨在回顾我们在儿童狼疮性肾炎(LN)方面的经验,分析LN的临床和组织病理学表现以及影响肾脏和患者预后的因素。
本研究纳入了43例经活检证实为LN的儿童(39例女孩,4例男孩)。儿童的平均年龄为12.0±2.8岁。根据肾脏组织病理学和临床表现,患者接受口服泼尼松、静脉注射甲泼尼龙脉冲或静脉注射环磷酰胺治疗。最终临床状态分类如下:(1)肾脏和肾外缓解;(2)临床活动性肾脏疾病,或(3)不良结局,即终末期肾衰竭(ESRF)或死亡。
平均随访时间为7.2±2.8年(1个月至14.2年)。所有43例儿童入院时均有血尿,53.5%有蛋白尿。14例儿童在疾病发作时处于肾病状态。29例患者观察到IV级(弥漫性增殖性)肾炎,为最常见的组织病理学类型(67.4%)。IV级肾炎患者在初始评估时有发生肾病综合征、大量蛋白尿、肌酐水平升高和持续性高血压的倾向。43例儿童中有32例(74.4%)在最后一次随访时处于肾脏缓解状态。全组从诊断到ESRF或死亡终点的5年肾脏和患者生存率分别为83.7%和90.7%,而IV级组分别为75.9%和86.2%。不良结局与就诊时持续性高血压、贫血、高血清肌酐水平、大量蛋白尿、肾病综合征和IV级肾炎显著相关。
我们可以得出结论,儿童LN的预后主要取决于组织病理学病变。在土耳其儿童中,入院时临床肾脏疾病的严重程度和持续性高血压的存在是主要的不良预后因素,而非年龄、性别、低C3和C4水平、ANA阳性及治疗方式。